Tim Sweeney, Co-Founder and CEO of Inflammatix, Joins Sepsis Alliance Board of Directors
Sepsis Alliance, the leading patient advocacy organization dedicated to saving lives and reducing suffering by improving sepsis awareness and care, is pleased to announce that Tim Sweeney, MD, PhD, has joined its Board of Directors.
Dr. Sweeney is cofounder and CEO of Inflammatix, a pioneer in decision-support diagnostics designed to identify critical illness earlier and improve sepsis and acute infection outcomes. He brings more than 20 years of experience working across the full spectrum of sepsis care and innovation, including clinical practice in general surgery and critical care, bench research, machine learning and artificial intelligence, and health policy and commercialization.Dr. Sweeney is cofounder and CEO of Inflammatix, a pioneer in decision-support diagnostics designed to identify critical illness earlier and improve sepsis and acute infection outcomes. He brings more than 20 years of experience working across the full spectrum of sepsis care and innovation, including clinical practice in general surgery and critical care, bench research, machine learning and artificial intelligence, and health policy and commercialization.
